Drozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)
A2758
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameDrozitumab (Anti-TNFRSF10B / TRAILR2 / CD262)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionDrozitumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal antibody targeted against the death receptor DR5 (TRAILR2, CD262, TNFRSF10B) with potent anti-tumor activity against rhabdomyosarcoma (RMS) xenografts. MW: 150 kD.
- Storage Instruction-20°C
- UNSPSC12352203